Suchergebnisse - Mark Guinter
- Treffer 1 - 1 von 1
-
1
The BEV1L study: Do real‐world outcomes associated with the addition of bevacizumab to first‐line chemotherapy in patients with ovarian cancer reinforce clinical trial findings?... von Linda R. Duska, Jonathan Lim, Tirza Areli Calderón Boyle, Mark Guinter, Siobhan Halloran, John Hartman, Jeanne M. Schilder, Jean A. Hurteau, Amanda K. Golembesky
Veröffentlicht 2025Volltext
Artículo Open Access